Suscribirse

Transcatheter closure of silent patent ductus arteriosus for prevention of endocarditis is justified - 14/08/21

Doi : 10.1016/j.acvdsp.2021.06.069 
Kaouther Hakim, MD, PhD, Maha Tagorti, MD , Hela Msaad, MD, PhD, Rihab Ben Othmen, MD, Khalil Ouaghlani, MD, Fatma Ouarda, MD, PhD
 Department of congenital heart diseases, La Rabta hospital, Tunis, Tunisia 

Corresponding author.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Resumen

Introduction

A diagnosis of ductal infective endocarditis (DIE) usually relies on the clinical histories of infectious syndrome, results of blood cultures and echocardiography. It remains a therapeutic challenge. The prognosis is still poor. Is the prevention of infective endarteritis a valid reason to always close the isolated silent PDA in childhood? The question is not yet eluded [1, 2, 3, 4].

We present the case of six years old girl with DIE developed after dental procedure. The patient was managed by combined medical and early surgery with favorable evolution.

Case report

A six year old girl was admitted to our service with tachypnea, fatigue and fever lasting for seven days. The patient had dental procedures few days earlier. The physical examination revealed a temperature at 40°C and a left subclavian murmur. The acute phase marker levels were significantly elevated and β-hemolytic group A streptococcus was grown in his blood culture. Echocardiography revealed vegetations with the diameter of 10mm on the left side of the PDA (Fig. 1) with turbulent flow in the left pulmonary artery. Treatment with ceftriaxone 200mg/kg/day and gentamycin 5mg/kg/day was started then readapted according to antibiogram. The operation was performed on day 15 of antibiotherapy (Fig. 2a and b), whom was continued for 4 weeks. The fever did not return and the clinical course of the patient was stable; the final echocardiogram revealed the absence of left ventricular dilatation with a correct systolic function, normal pulmonary pressure. She was discharged four weeks after the surgical cardiac procedure.

Conclusions

Infective endarteritis (IE) complicating PDA is very rare nowadays and the risk is very low especially in the industrialized world. Indeed, standardized management by a skilled multidisciplinary team with expertise in imaging, surgery and intensive care has proven to decrease mortality [3, 4, 5, 6, 7]. Primary prevention is vital. Even though it was not clear if the closure of a small PDA was beneficial, routine closure of any PDA in children and young adults appeared reasonable. The reasons for this recommendation included the risk of infective endocarditis and low-or-zero morbidity from closure, especially when using a transcatheter device [8, 9].

El texto completo de este artículo está disponible en PDF.

Keywords : Patent ductus arteriosus, Infective endocarditis, Catheterization, Surgical repair


Esquema


© 2021  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 13 - N° 4

P. 310-311 - septembre 2021 Regresar al número
Artículo precedente Artículo precedente
  • Interrupted aortic arch: Is it always a neonatal emergency?
  • Maha Tagorti, Kaouther Hakim, Hela Msaad, Khalil Ouaghlani, Rihab Ben Othmen, Fatma Ouarda
| Artículo siguiente Artículo siguiente
  • Histiocytoid cardiomyopathy management at the era of extracorporeal membrane assistance (ECMO): A series of 4 cases
  • Alice Maltret, Fanny Bajolle, Nicolas Combes, Nadir Benbrik, Olivia Domanski, Daphné Vens, Lucile Houyel, Damien Bonnet

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.